首页> 美国卫生研究院文献>Medical Science Monitor : International Medical Journal of Experimental and Clinical Research >Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma
【2h】

Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma

机译:miR-26a和多形性腺瘤基因1(PLAG1)在侵袭性垂体腺瘤中的表达及其临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAlthough pituitary adenoma is a malignant tumor, it can present as invasive growth in some cases. MicroRNA (miR)-26a has been found to be abnormally highly expressed in pituitary adenoma, indicating possible involvement in pathogenesis. As a known target gene of miR-26a, PLAG1 has abnormally low expression in pituitary adenoma. The correlation between miR-26a or PLAG1 expressional abnormality and occurrence of pituitary adenoma is still unknown, as is its association with invasiveness of pituitary adenoma.
机译:背景尽管垂体腺瘤是一种恶性肿瘤,但在某些情况下可能以侵袭性生长的形式出现。已发现MicroRNA(miR)-26a在垂体腺瘤中异常高表达,表明可能参与了发病机理。作为miR-26a的已知靶基因,PLAG1在垂体腺瘤中异常低表达。 miR-26a或PLAG1表达异常与垂体腺瘤发生之间的相关性尚不清楚,其与垂体腺瘤浸润性的相关性也未知。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号